Evidence map›Paper›PMID 39188790›Full record

ArticleFrontiers in public health2024

Impact of recruitment strategies on individual participation practices in the Canadian National Vaccine Safety Network: prospective cohort study.

Phyumar Soe, Manish Sadarangani, Monika Naus, Matthew P Muller, Otto G Vanderkooi, James D Kellner, Karina A Top, Hubert Wong, Jennifer E Isenor, Kimberly Marty and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Phyumar SoeVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Manish SadaranganiVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Monika NausSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Matthew P MullerDepartment of Medicine, Unity Health Toronto, Toronto, ON, Canada.
Otto G VanderkooiDepartment of Pediatrics and Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada.
James D KellnerDepartment of Pediatrics and Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada.
Karina A TopDepartment of Pediatrics, Canadian Center for Vaccinology, IWK Health, Dalhousie University, Halifax, NS, Canada.
Hubert WongSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Jennifer E IsenorDepartment of Pediatrics, Canadian Center for Vaccinology, IWK Health, Dalhousie University, Halifax, NS, Canada.
Kimberly MartyVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Gaston De SerresCollege of Pharmacy, Dalhousie University, Halifax, NS, Canada.
Louis ValiquetteDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, QC, Canada.
Allison McGeerDepartment of Microbiology, Sinai Health System, Toronto, ON, Canada.
Julie A BettingerVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Canadian Immunization Research Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Canadian National Vaccine Safety (CANVAS) network conducted a multi-center, prospective vaccine safety study to collect safety data after dose 1 and 2 of COVID-19 vaccines and follow up safety information 7 months after dose 1. Objective: This study aimed to describe and evaluate the recruitment methods used by CANVAS and the retention of participants by each modality. Methods: CANVAS deployed a multi-pronged recruitment approach to reach a larger sample, without in-person recruitment. Three primary recruitment strategies were used: passive recruitment, technology-assisted electronic invitation through the vaccine booking system (auto-invitation), or auto-registration through the vaccine registries (auto-enrollment). Results: Between December 2020 and April 2022, approximately 1.3 million vaccinated adults either self-enrolled or were auto-enrolled in CANVAS, representing about 5% of the vaccinated adult Canadian population. Approximately 1 million participants were auto-enrolled, 300,000 were recruited by auto-invitation, and 5,000 via passive recruitment. Overall survey completion rates for dose 1, dose 2 and the 7-month follow-up surveys were 51.7% (681,198 of 1,318,838), 54.3% (369,552 of 681,198), and 66.4% (452,076 of 681,198), respectively. Completion rates were lower among auto-enrolled participants compared to passively recruited or auto-invited participants who self-enrolled. However, auto-enrolled samples were much larger, which offset the lower completion rates. Conclusion: Our data suggest that auto-enrollment provided an opportunity to reach and retain a larger number of individuals in the study compared to other recruitment modalities.

Indexed as

COVID-19COVID-19 VaccinesPatient SelectionAdultAgedCanadaFemaleHumansMaleMiddle AgedProspective StudiesSARS-CoV-2VaccinationCOVID-19 Vaccinesauto-enrollmentauto-invitationCOVID-19 vaccinestechnology-assisted active recruitmentvaccine safety

Identifiers

PMID39188790
PMCPMC11345188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.